Comparative antibacterial activity of an arylglycyl oral cephalosporin, LY164846.
LY164846 is a semisynthetic arylglycyl cephalosporin which can be absorbed orally. It had in vitro activity comparable to that of cefaclor against beta-hemolytic streptococcal species and was two- to fourfold more active than cephalexin. Enterococci and Listeria species were resistant, and its activ...
Guardat en:
| Publicat a: | Antimicrob Agents Chemother |
|---|---|
| Autors principals: | , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
American Society for Microbiology (ASM)
1986
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC180471/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/3486632/ https://ncbi.nlm.nih.govhttps://doi.org/10.1128/aac.29.4.703 |
| Etiquetes: |
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|